Severe Hypoglycemia in Diabetes Drug Approved in Europe
A marketing authorization for Zegalogue (dasiglucagon, Zealand Pharma) for the treatment of severe hypoglycemia in patients aged 6 years and older ...
Read moreA marketing authorization for Zegalogue (dasiglucagon, Zealand Pharma) for the treatment of severe hypoglycemia in patients aged 6 years and older ...
Read moreConcerns over hypoglycemia risk with an investigational once-weekly insulin product in patients with type 1 diabetes prompted the FDA to ...
Read moreTOPLINE:Older adults (aged ≥ 65 years) with diabetes who received insulin may have an increased risk for serious hypoglycemic events ...
Read more© 2023 earth-news.info